AstraZeneca

AstraZeneca is a top pharmaceutical company based in London, United Kingdom

AstraZeneca is a top pharmaceutical company based in London, United Kingdom.The company source its origins back to 1913, however the most recent incarnation is the result of numerous M&A deals over the decades resulting in the 1999 merger between Astra of Sweden and Zeneca of the United Kingdom.AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

Report: Partnering Deals and Alliances with AstraZeneca

AstraZeneca is a top pharmaceutical company based in London, United Kingdom.

The company source its origins back to 1913, however the most recent incarnation is the result of numerous M&A deals over the decades resulting in the 1999 merger between Astra of Sweden and Zeneca of the Unted Kingdom.

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.

AstraZeneca has a well-defined business development strategy which is focused on supplementing the discovery, development and commercialisation of innovative medicines in our core therapy areas and complementing technology capabilities through partnerships more

AstraZeneca announced over 220 partnering / licensing deals since 2005, with 41 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, psychiatry, cardiovascular, respiratory and gastrointestinal diseases more

AstraZeneca has also announced 7 M&A deals since 2005, with the lead deals being the acquisition of MedImmune, Ardea Biosciences and Astra Tech more

Report: Partnering Deals and Alliances with AstraZeneca

Examples of recent partnering and licensing deals announced by AstraZeneca can be viewed in Current Partnering's AstraZeneca: Partnering activity 2005-2013 review article.

Examples of recent M&A deals announced by AstraZeneca can be viewed in Current Partnering's AstraZeneca: M&A activity 2005-2013 review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with AstraZeneca

Available reports from Current Partnering

Report: Partnering Deals and Alliances with AstraZeneca                                 

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for AstraZeneca  

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on AstraZeneca company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email